Allergen-specific immunotherapy for atopic eczema: Updated

Current Opinion in Allergy and Clinical Immunology

Volumn 12, Issue 6, 2012, Pages 665-669

  Darsow, Ulf ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Allergen immunotherapy; Atopic dermatitis; Atopic eczema

Indexed keywords

ALLERGEN; GLUCOCORTICOID;

ALLERGEN SPECIFIC IMMUNOTHERAPY; ATOPIC DERMATITIS; CORTICOSTEROID THERAPY; DERMATOPHAGOIDES PTERONYSSINUS; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; PATCH TEST; PRIORITY JOURNAL; REVIEW; SENSITIZATION; T LYMPHOCYTE; TH1 CELL;

DERMATITIS, ATOPIC; DESENSITIZATION, IMMUNOLOGIC; HUMANS; PATCH TESTS; TH1 CELLS; TH2 CELLS;

EID: 84871319374     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e3283588cf4     Document Type: Review

References (21)

1. Ring J, Alomar A, Bieber T, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol 2012; 26:1045-1060
2. Novak N, Werfel T. Specific immunotherapy and atopic dermatitis: what is new? Hautarzt 2011; 62:650-656
3. Darsow U, Forer I, Ring J. Allergen-specific immunotherapy in atopic eczema. Curr Allergy Asthma Rep 2011; 11:277-283
4. Darsow U, Ring J. IgE-mediated allergy plays a role in atopic eczema as shown in the atopy patch test. WAO J 2008; 1:51-56
5. Ring J, Gutermuth J. 100 years of hyposensitization: history of allergenspecific immunotherapy (ASIT). Allergy 2011; 66:713-724
6. Weller K, Soost S, Worm M, et al. Atopic dermatitis and allergic rhinitis: do coeffects in therapy exist? J Dtsch Dermatol Ges 2012; 10:221-236
7. Glover MT, Atherton DJ. A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema. Clin Exp Allergy 1992; 22:440-446
8. Werfel T, Breuer K, Rueff F, et al. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multicentre, randomized, dose-response study. Allergy 2006; 61:202-205
9. Silny W, Czarnecka-Operacz M. Specific immunotherapy in the treatment of patients with atopic dermatitis. Results of a placebo-controlled double-blind study [in German]. Allergologie 2006; 29:171-183
10. Cadario G, Galluccio AG, Pezza M, et al. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study. Curr Med Res Opin 2007; 23:2503-2506
11. Pajno GB, Caminiti L, Vita D, et al. Sublingual immunotherapy in mitesensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol 2007; 120:164-170
12. Bussmann C, Maintz L, Hart J, et al. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study. Clin Exp Allergy 2007; 37:1277-1285
13. Nahm DH, Lee ES, Park HJ, et al. Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamineimmunoglobulin complex. Int Arch Allergy Immunol 2008; 146:235-240
14. Kwon YS, Oh SH, Wu WH, et al. CC chemokines as potential immunologic markers correlated with clinical improvement of atopic dermatitis patients by immunotherapy. Exp Dermatol 2010; 19:246-251
15. Novak N, Thaci D, Hoffmann M, et al. Subcutaneous immunotherapy with a depigmented polymerized birch pollen extract: a new therapeutic option for patients with atopic dermatitis. Int Arch Allergy Immunol 2011; 155:252-256
16. Novak N, Zuberbier T, Sager A. Efficacy and safety of a depigmented polymerised mite extract in patients suffering from atopic eczema with clinically relevant IgE-mediated sensitisation against house dust mites. Allergy 2011; 66 (Suppl 94):103
17. Darsow U, Wollenberg A, Simon D, et al., for the European Task Force on Atopic Dermatitis /EADV Eczema Task Force. ETFAD /EADV Eczema Task Force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2010; 24:317-328
18. Ring J, Alomar A, Bieber T, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part II. J Eur Acad Dermatol Venereol 2012; 26:7776-7777
19. Olze H, Zuberbier T. Comorbidities between nose and skin allergy. Curr Opin Allergy Clin Immunol 2011; 11:457-463
20. WHO Collaborating Center for Asthma and Rhinitis. Severe chronic allergic (and related) diseases: a uniform approach-A MeDALL-GA(2)LEN-ARIA Position Paper. Int Arch Allergy Immunol 2012; 158:216-231.
21. Ring J, Akdis C, Behrendt H, et al. Davos Declaration. Allergy as a global problem. Allergy 2012; 67:141-142